Evidence map›Paper›PMID 38338988›Full record

Observational studyInternational journal of molecular sciences2024

New Insights into the Pro-Inflammatory and Osteoclastogenic Profile of Circulating Monocytes in Osteoarthritis Patients.

Paloma Guillem-Llobat, Marta Marín, Matthieu Rouleau, Antonio Silvestre, Claudine Blin-Wakkach, María Luisa Ferrándiz, María Isabel Guillén, Lidia Ibáñez

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Synthesis, characterisation, andFrontiers in drug delivery · 2026
    Article
  6. Review
  7. Innate Immunity and Synovitis: Key Players in Osteoarthritis Progression.International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Paloma Guillem-LlobatDepartment of Biomedical Science, Cardenal Herrera-CEU University, 46115 Valencia, Spain.
Marta MarínDepartment of Pharmacy, Cardenal Herrera-CEU University, 46115 Valencia, Spain.
Matthieu RouleauLaboratory of Molecular PhysioMedicine, UMR 7370, National Centre for Scientific Research, Côte d'Azur University, 06107 Nice, France.ORCID 0000-0002-0075-9880
Antonio SilvestreService of Orthopedic Surgery and Traumatology, University Clinical Hospital, 46010 Valencia, Spain.ORCID 0000-0002-6561-8704
Claudine Blin-WakkachLaboratory of Molecular PhysioMedicine, UMR 7370, National Centre for Scientific Research, Côte d'Azur University, 06107 Nice, France.
María Luisa FerrándizInteruniversity Research Institute for Molecular Recognition and Technological Development (IDM), Polytechnic University of Valencia and University of Valencia, 46022 Valencia, Spain.ORCID 0000-0003-4059-0175
María Isabel GuillénDepartment of Pharmacy, Cardenal Herrera-CEU University, 46115 Valencia, Spain.
Lidia IbáñezDepartment of Pharmacy, Cardenal Herrera-CEU University, 46115 Valencia, Spain.ORCID 0000-0002-2217-8817
Universidad Cardenal Herrera CEU · ESLaboratoire de PhysioMédecine Moléculaire · FRHospital Clínico Universitario de Valencia · ESUniversitat Politècnica de València · ES

Funding

Cardenal Herrera-CEU University INDI 18/22, INDI20/24, INDI21/27 and INDI22/28CEU Universities and Banco Santander Grant number FUSPBS-PPC07/2018Generalitat Valenciana Grant number GV/2020/136Ministerio Ciencia e Innovación Grant number PID2021-124890OB-I00
6 · The paper itself

Abstract

Osteoarthritis (OA) is a degenerative condition of the articular cartilage with chronic low-grade inflammation. Monocytes have a fundamental role in the progression of OA, given their implication in inflammatory responses and their capacity to differentiate into bone-resorbing osteoclasts (OCLs). This observational-experimental study attempted to better understand the molecular pathogenesis of OA through the examination of osteoclast progenitor (OCP) cells from both OA patients and healthy individuals (25 OA patients and healthy samples). The expression of osteoclastogenic and inflammatory genes was analyzed using RT-PCR. The OA monocytes expressed significantly higher levels of CD16, CD115, TLR2, Mincle, Dentin-1, and CCR2 mRNAs. Moreover, a flow cytometry analysis showed a significantly higher surface expression of the CD16 and CD115 receptors in OA vs. healthy monocytes, as well as a difference in the distribution of monocyte subsets. Additionally, the OA monocytes showed a greater osteoclast differentiation capacity and an enhanced response to an inflammatory stimulus. The results of this study demonstrate the existence of significant differences between the OCPs of OA patients and those of healthy subjects. These differences could contribute to a greater understanding of the molecular pathogenesis of OA and to the identification of new biomarkers and potential drug targets for OA.

Indexed as

MonocytesOsteoarthritisBone and BonesHumansInflammationOsteoclastsbone remodelinginflammationmonocyteosteoarthritisosteoclast progenitor

Identifiers

PMID38338988
PMCPMC10855447
OpenAlexW4391362648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.